New Key Statistics Module, Z-Score and F-Score
NYSE:ANVS Key Ratios
Market Cap $ M | 105.08 |
Enterprise Value $ M | 104.74 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -4.50 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -116.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.56 |
EV-to-EBITDA | -2.56 |
PEG | -- |
Shares Outstanding M | 13.05 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 1.24 |
Current Ratio | 1.24 |
ROA % (ttm) | -383.35 |
ROE % (ttm) | -1,478.76 |
ROIC % (ttm) | -1,843.22 |
Dividend Yield % | -- |
Altman Z-Score | -- |
ANVS Number of Guru Trades
ANVS Volume of Guru Trades
Gurus Latest Trades with NYSE:ANVS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ANVS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Annovis Bio Inc Insider Transactions
No Available Data
News about NYSE:ANVS
Total 0- 1